financetom
Business
financetom
/
Business
/
Vans parent VF Corp beats quarterly estimates on strong demand amid tariff pressure
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vans parent VF Corp beats quarterly estimates on strong demand amid tariff pressure
Oct 28, 2025 4:24 AM

Oct 28 (Reuters) - Vans parent VF Corp ( VFC ) posted

better-than-expected results for the second quarter on Tuesday,

helped by strong demand for its footwear, bags and lifestyle

apparel, even as economic uncertainty looms.

Shares of the Denver, Colorado-based company were up about

4% in premarket trading.

The Timberland maker's upbeat results come against a

backdrop of mounting pressure across the U.S. retail sector,

where apparel and accessories companies are struggling to keep

up with the impact of tariffs imposed by President Donald Trump.

The tariffs have disrupted key sourcing regions such as

Vietnam and Indonesia, which are critical to the global supply

chain for sportswear and apparel.

VF Corp ( VFC ), which sources the majority of its products from

Southeast Asia and the Americas, has responded by ramping up

production and shipments, working with suppliers to manage

costs, and considering pricing strategies to offset the impact.

The company's latest collections across brands helped boost

sales, with revenue for the North Face brand rising 6% in the

reported quarter, while Timberland surged 7%. Vans, however,

declined 9% from a year earlier, though the drop moderated from

the 14% fall in the prior quarter.

The company's revenue of $2.80 billion for the quarter ended

September 27, beat analysts' estimate of $2.74 billion,

according to data compiled by LSEG.

It posted a quarterly adjusted profit of 52 cents per share

versus an estimated profit of 43 cents per share.

In September, the company announced plans to sell its

workwear brand Dickies for $600 million in cash to brand

management company Bluestar Alliance as a turnaround move to

navigate through rising economic uncertainty.

The apparel retailer, however, expects third-quarter

revenue, excluding Dickies, to fall between 3% and 1%, compared

with estimates of a 1.54% rise, according to data compiled by

LSEG.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MediaAlpha Closes $144.2 Million Secondary Offering
MediaAlpha Closes $144.2 Million Secondary Offering
May 10, 2024
09:30 AM EDT, 05/10/2024 (MT Newswires) -- MediaAlpha ( MAX ) announced Friday the closing of a secondary offering of nearly 7.6 million class A common shares previously owned by affiliates of White Mountains Insurance Group ( WTM ) and Insignia Capital Group at $19 apiece, generating $144.2 million in gross proceeds for the selling shareholders. Underwriters for the deal...
Rocket Pharmaceuticals Says Blood Disorder Therapies Show Promise
Rocket Pharmaceuticals Says Blood Disorder Therapies Show Promise
May 10, 2024
09:28 AM EDT, 05/10/2024 (MT Newswires) -- Rocket Pharmaceuticals ( RCKT ) said Friday that longer-term data on its experimental gene therapies to treat patients with rare blood disorders showed sustained safety and efficacy. Kresladi, a treatment for severe leukocyte adhesion deficiency, showed 100% stem cell transplantation-free survival with significant reductions in infection-related hospitalizations following engraftment, the company said. Data...
FDA Delays 'Important' Moderna Vaccine Review: William Blair Says 2025 Growth, '2026 Breakeven Story' Depends On It
FDA Delays 'Important' Moderna Vaccine Review: William Blair Says 2025 Growth, '2026 Breakeven Story' Depends On It
May 10, 2024
The Food and Drug Administration (FDA) notified Moderna Inc ( MRNA ) on Friday that its review of a new vaccine has been delayed. The agency, citing administrative constraints, does not expect to complete its review of the Biologics License Application (BLA) for mRNA-1345, Moderna’s investigational respiratory syncytial virus (RSV) vaccine, by the Prescription Drug User Fee Act date of May 12, 2024. ...
Bunge halts soy crushing plant in Brazil's flood-hit state
Bunge halts soy crushing plant in Brazil's flood-hit state
May 10, 2024
SAO PAULO, May 10 (Reuters) - Bunge has temporarily suspended activities at its soybean crushing unit and port terminal in the city of Rio Grande, a statement sent to Reuters on Friday said. The suspension, effective from Thursday, was taken due to forecasts of possible flooding in the region in the coming days. Brazil is the world's largest soybean producer...
Copyright 2023-2026 - www.financetom.com All Rights Reserved